CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Immuron Limited Company Snapshot
Immuron Limited operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Immuron Limited with three other pharmaceutical manufacturers in Australasia: Paradigm Biopharmaceuticals Ltd (2018 sales of 2.74 million Australian Dollars [US$1.98 million] ), Acrux Ltd (3.43 million Australian Dollars [US$2.48 million] of which 100% was Pharmaceutical Research and Development), and Pharmaust Limited (3.30 million Australian Dollars [US$2.38 million] ).

Sales Analysis. During the year ended June of 2018, sales at Immuron Limited were A$3.69 million (US$2.67 million). This is an increase of 23.9% versus 2017, when the company's sales were A$2.98 million. This was the fifth consecutive year of sales increases at Immuron Limited (and since 2013, sales have increased a total of 2,366%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Immuron Limited
  Stock Performance Chart for Immuron Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (11/9/2018): .29
(Figures in Australian Dollars)
1 Week 3.6%   13 Weeks -3.4%  
4 Weeks -20.8%   52 Weeks 58.3%  
 
Immuron Limited Key Data:
  Ticker: IMC Country: Australia
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2018 Sales 3,693,270
(Year Ending Jan 2019).
Employees: 25
  Currency: Australian Dollars Market Cap: 40,691,789
  Fiscal Yr Ends: June Shares Outstanding: 142,778,206
  Share Type: Ordinary Closely Held Shares: 52,908,790
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.